Harmony Biosciences Holdings, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462
Mailing Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462
Phone
(484) 539-9800
Fiscal Year End
1231
EIN
822279923
Financial Overview
FY2025
$401.41M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 14, 2026 | View on SEC |
| 4 Insider stock transaction report | April 9, 2026 | View on SEC |
| 3 Initial insider ownership report | April 6, 2026 | View on SEC |
| 4 Insider stock transaction report | April 6, 2026 | View on SEC |
| 4 Insider stock transaction report | April 6, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | April 3, 2026 | View on SEC |
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 10-K Annual financial report | February 24, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
Material Events
8-K
Leadership Change
April 14, 2026
High Impact
- Appointment of Glenn Reicin as CFO, signaling a strategic shift toward capital deployment and growth.
- Reiteration of strong 2026 revenue guidance of $1.0B to $1.04B.
8-K
Leadership Change
April 2, 2026
High Impact
- Strategic leadership overhaul to transition from single-product to mature pharma player
- Appointment of Peter Anastasiou as COO to drive operational execution
Insider Trading
STRONG SELL
2 insiders
6 recent transactions
View Insider Trading Dashboard
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.